Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

CNA earnings analysis

Filed August 3, 2026 · Our reading of the company's report

The latest report

CNA delivered Q2 operating-revenue growth of $71 million to $3.834 billion and reported net income of $321 million, up $22 million year over year, with EPS of $1.18. However, core income declined $11 million to $324…

Read full summary

CNA delivered Q2 operating-revenue growth of $71 million to $3.834 billion and reported net income of $321 million, up $22 million year over year, with EPS of $1.18. However, core income declined $11 million to $324 million as P&C underwriting gain fell from $150 million to $92 million; higher $701 million investment income partially mitigated weaker underlying loss ratios. Premium momentum remained favorable in Specialty and Commercial, while International written premiums declined and all three P&C segments experienced combined-ratio deterioration. Cash generation stayed substantial at $1.042 billion for the first half, though it declined $158 million year over year; the filing provides no numeric earnings or revenue guidance.

Read the original on SEC.gov

Where revenue came from

The business segments reported by the company.

Commercial 53.6% Specialty 30.5% International 12.5% Life & Group 3.4%

Shares of the segments disclosed in this filing, largest first.

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish Feb 2023 Aug 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

Reported figures

Earnings per share
$1.18

What stood out

  • Revenue and reported earnings increased

    Q2 total operating revenues rose $71 million, or 1.9%, year over year to $3.834 billion, and increased $154 million, or 4.2%, from Q1 2026 revenue of $3.680 billion. Net income increased $22 million to $321 million, while diluted EPS was $1.18 versus $1.10 in Q2 2025.

  • Investment income offset underwriting pressure

    Net investment income increased $39 million year over year to $701 million, driven by higher limited-partnership/common-stock returns and higher fixed-income income. The fixed-income portfolio's effective income yield held at 4.9%.

  • Commercial premium growth remained solid

    Commercial net written premiums increased $80 million to $1.643 billion, supported by favorable renewal premium change and higher new business; new business rose $26 million to $446 million. Segment core income nevertheless rose $14 million to $232 million due to investment income.

  • Specialty growth driven by new business and rate

    Specialty net written premiums rose $45 million to $937 million, with new business increasing $53 million to $175 million and renewal rate improving to 4% from 3%.

  • Operating cash flow funded shareholder returns

    Six-month operating cash flow was $1.042 billion, despite declining $158 million from $1.200 billion a year earlier; the company returned $848 million through $812 million of dividends and $36 million of buybacks.

  • Revolver remains fully undrawn

    Liquidity remained available: there were no borrowings under the $250 million senior unsecured revolving credit facility and no FHLBC borrowings outstanding at June 30, 2026.

What to watch

  • Underlying underwriting profitability weakened

    P&C underwriting gain fell $58 million year over year to $92 million, and underlying underwriting gain declined $60 million to $153 million. Specialty's combined ratio worsened 2.9 points to 96.5%, Commercial's rose 1.7 points to 96.5%, and International's increased 4.1 points to 96.9%.

  • Reserve-development and legacy mass-tort exposure

    The company recorded $91 million of unfavorable prior-year loss reserve development in Q2 2026. Corporate & Other included a $77 million after-tax charge, largely associated with legacy mass-tort abuse reserves.

  • Casualty severity and expense headwinds

    Commercial's Q2 loss ratio increased 2.4 points to 69.5%, primarily from excess casualty and workers' compensation; International's expense ratio rose 2.0 points to 34.9% amid talent and technology investments and higher acquisition costs.

Management's outlook

The 10-Q contains no quantitative earnings or revenue outlook. Management states that present cash flows are sufficient for current and expected working-capital and debt-obligation needs and that it does not expect this to change in the near term.

Earlier filings 4

10-Q · May 4, 2026

CNA Financial Corporation reported Q1 2026 earnings with revenue of $666 million and an EPS of $1.37, both exceeding expectations. The company raised its full-year EPS guidance to a range of $5.30 to $5.50 due to strong…

10-K · February 10, 2026

CNA's 2025 results show revenue and earnings expansion with total revenues of $14,989 million (2025 vs. $14,270 million in 2024) and diluted EPS of $4.69 (2025 vs. $3.52 in 2024). Operating cash flow remained strong at…

10-Q · November 3, 2025

CNA reported higher top-line and materially improved underwriting and investment results in Q3 2025: total operating revenues were $3,824 million (Q3 2025) vs. $3,628 million (Q3 2024), and core income rose to $409…

10-Q · August 4, 2025

CNA Financial reported strong Q2 2025 results, with revenue reaching $3.72 billion, up 5.7% year-over-year, driven primarily by commercial insurance growth. EPS exceeded expectations at $1.23, a notable increase from…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.